Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Youngevity Essential Life Sciences, a subsidiary of AL International, has entered into an agreement to commence a series of clinical research studies at the Clemson University's Institute of Nutraceutical Research.
Subscribe to our email newsletter
The placebo-controlled, validation research studies will evaluate potential effects of Youngevity products including 90 Essential Nutrients blend on human inflammation, bacterial, and disease management biomarkers.
Youngevity CEO Steve Wallach said the company is looking forward to work with Chittaranjan Kole, research director, at the Clemson University to perform clinical research studies, which will allow to study potential links between its products and various biomarkers.
The company said Clemson University studies, which will immediately begin studies, will conclude the study results by the end of 2012.
Youngevity cofounder Joel Wallach said, "Ongoing research with respected and reputable academic institutions such as Clemson extends our commitment to provide the best products to our distributors and customers."